
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
[ Mon, Jun 24th 2024 ]: WOPRAI
Kostas Biliouris Maintained (ALNY) at Buy and Held Target at $234 on, Jun 24th, 2024


🞛 This publication is a summary or evaluation of another publication
Kostas Biliouris of BMO Capital, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy and Held Target at $234 on, Jun 24th, 2024.
Kostas has made no other calls on ALNY in the last 4 months.
There are 2 other peers that have a rating on ALNY. Out of the 2 peers that are also analyzing ALNY, 0 agree with Kostas's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Kostas
- Whitney Ijem of "Canaccord Genuity" Maintained at Strong Buy and Held Target at $283 on, Friday, June 21st, 2024
- Keay Nakae of "Chardan Capital" Maintained at Strong Buy and Held Target at $225 on, Friday, May 3rd, 2024